Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Renity Pharma AB
AB
Active
Org 5594796137
Kanalvägen 61, 191 34
Sollentuna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 2 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Renity Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PF
Per Fredrik Lehmann
Chief Executive Officer
Chief Executive Officer
2024
AP
Anders Patrik Nygard
Chief Auditor
Chief Auditor
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
TE
Tobias Erik Martin Larsson Agervald
Board of Directors
Board of Directors
2025
CJ
Carl Johan Kördel
Board of Directors
Board of Directors
2024
PF
Per Fredrik Lehmann
Board of Directors
Board of Directors
2025
KB
Krim Benaissa Talia
Chairman
Chairman
2025
Shareholders
As of last annual report
OT Pharmaceuticals AB — 100%
100%
Shareholder
Type
Ownership
Votes
Since
OT Pharmaceuticals AB
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Renity Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
